Different Mutational Profiles of Subcutaneous Panniculitis-like T-cell Lymphoma and Lupus Panniculitis: An Additional Case Series
Actas Dermo-Sifiliográficas · 2025
DOI: 10.1016/j.ad.2024.06.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Actas Dermo-Sifiliográficas, 2025. Verfasst von S Machan und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Fundación Jiménez Díaz-IIS, Universidad Autónoma de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Panniculitis, Lymphoma, T-Cell, Panniculitis, Lupus Erythematosus, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Centro de Investigación Biomédica en Red de Cáncer, Ministerio de Ciencia e Innovación, H2020 Marie Skłodowska-Curie Actions.
Abstract (Originalsprache)
BACKGROUND: Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare cytotoxic T-cell lymphoma with indolent behavior, mostly present in women and associated with immunological diseases whose pathogenic background is still poorly understood. SPTCL is associated with lupus erythematosus panniculitis (LEP) and histologically misdiagnosed. OBJECTIVES: The aim of our study was to identify mutations affecting the pathogenesis of both SPTCL and LEP. MATERIALS AND METHODS: We studied a total of 10 SPTCL and 10 LEP patients using targeted next-generation sequencing and pyrosequencing. Differences in gene expression between molecular subgroups were investigated using NanoString technology. Clinical data were collected, and correlations sought with the molecular data obtained. RESULTS: The mutational profile of SPTCL and LEP is different. We identified fewer pathogenic mutations than previously reported in SPTCL, noting a single HAVCR2-mutated SPTCL case. Interestingly, 40% of our SPTCL cases showed the pathogenic TP53 (p.Pro72Arg) (P72R) variant. Although cases showing HAVCR2 mutations or the TP53 (P72R) variant had more severe symptomatic disease, none developed hemophagocytic syndrome (HPS). Furthermore, TP53 (P72R)-positive cases were characterized by a lower metabolic signaling pathway and higher levels of CD28 expression and Treg signaling genes. In addition, 30% of our cases featured the same mutation (T735C) of the epigenetic modificatory gene DNMT3A. None of the LEP cases showed mutations in any of the studied genes. CONCLUSIONS: The mutational landscape of SPTCL is broader than previously anticipated. We describe, for the first time, the involvement of the TP53 (P72R) pathogenic variant in this subgroup of tumors, consider the possible role of different genetic backgrounds in the development of SPTCL, and conclude that LEP does not follow the same pathogenic pathway as SPTCL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Fundación Jiménez Díaz-IIS, Universidad Autónoma de Madrid, Madrid, Spain.
- Department of Pathology, Fundación Jiménez Díaz-IIS, Universidad Autónoma de Madrid, Madrid, Spain; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Spain.
- Department of Pathology, Fundación Jiménez Díaz-IIS, Universidad Autónoma de Madrid, Madrid, Spain; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Spain. Electronic address: rebeca.manso@quironsalud.es.
- Hospital Universitario 12 de Octubre, Madrid, Spain.
- Hospital Universitario Río Hortega, Valladolid, Spain.
- Hospital Clínico Universitario de Valencia, Universidad de Valencia, Valencia, Spain.
Förderung
- Centro de Investigación Biomédica en Red de Cáncer
- Ministerio de Ciencia e Innovación
- H2020 Marie Skłodowska-Curie Actions
- Instituto de Salud Carlos III
Zitieren
APA
Machan, S., Rodríguez, M., Manso, R., Borregón, J., Chamizo, C., Alonso-Alonso, R., Rodríguez-Peralto, J. L., Torres Nieto, M. Á., Monteagudo, C., García Toro, E., Cerroni, L., García, C., Estrach, T., García Herrera, A., Ferrer, B., García-Patos, V., Segues, N., Díaz de la Pinta, F. J., Afonso-Martin, J. L., …, & Rodríguez-Pinilla, S. M. (2025). Different Mutational Profiles of Subcutaneous Panniculitis-like T-cell Lymphoma and Lupus Panniculitis: An Additional Case Series. Actas Dermo-Sifiliográficas. https://doi.org/10.1016/j.ad.2024.06.006
Vancouver
Machan S, Rodríguez M, Manso R, Borregón J, Chamizo C, Alonso-Alonso R, et al. Different Mutational Profiles of Subcutaneous Panniculitis-like T-cell Lymphoma and Lupus Panniculitis: An Additional Case Series. Actas Dermo-Sifiliográficas. 2025. doi:10.1016/j.ad.2024.06.006
BibTeX
@article{Machan2025,
author = {Machan, S and Rodríguez, M and Manso, R and Borregón, J and Chamizo, C and Alonso-Alonso, R and Rodríguez-Peralto, J L and Torres Nieto, M Á and Monteagudo, C and García Toro, E and Cerroni, L and García, C and Estrach, T and García Herrera, A and Ferrer, B and García-Patos, V and Segues, N and Díaz de la Pinta, F J and Afonso-Martin, J L and Peñate, Y and Limeres-Gonzalez, M Á and González-Núñez, M Á and González-Cruz, C and García Fernández, E and Cereceda, L and Minguez, P and de la Fuente, L and Requena, L and Rodríguez-Pinilla, S M},
title = {Different Mutational Profiles of Subcutaneous Panniculitis-like T-cell Lymphoma and Lupus Panniculitis: An Additional Case Series},
journal = {Actas Dermo-Sifiliográficas},
year = {2025},
doi = {10.1016/j.ad.2024.06.006}
}
EUVIMED